{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:22:22Z","timestamp":1791969742984,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["894-791"],"award-info":[{"award-number":["894-791"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["956-799"],"award-info":[{"award-number":["956-799"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/Z504105\/1"],"award-info":[{"award-number":["MR\/Z504105\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF005\\1064"],"award-info":[{"award-number":["SBF005\\1064"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neurocare"},{"name":"My Name'5 Doddie Foundation","award":["DOD\/14\/43"],"award-info":[{"award-number":["DOD\/14\/43"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NF-SI-0617-10077"],"award-info":[{"award-number":["NF-SI-0617-10077"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022572","name":"NIHR Sheffield Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR 203321"],"award-info":[{"award-number":["NIHR 203321"]}],"id":[{"id":"10.13039\/501100022572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with limited therapeutic options. The circulating metabolome comprises small molecules present in plasma\/serum which are the intermediates and end-products of cellular metabolism, and is linked to ALS pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted hypothesis-free two-sample Mendelian randomisation (MR) analysis of the concentration of 575 plasma\/serum metabolites, to determine which are causally linked to risk of ALS. Significant metabolites were validated in an independent GWAS of plasma\/serum metabolite concentrations and evaluated for sex-specific effects. Correlations between directly measured patient biofluid metabolite concentrations and ALS risk\/severity were examined in 94 ALS patients and 40 controls. We experimentally assessed metabolic function in a murine neurons and human astrocytes carrying an ALS-associated G4C2-repeat expansion within\n                      <jats:italic>C9orf72<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MR causally associated five metabolites with ALS risk after multiple-testing correction. Higher serum concentration of glycoprotein acetyls (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20099.7e\u2009\u2212\u20099,\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.21) and the peptide DSGEGDFXAEGGGVR (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20098.0e\u2009\u2212\u20096,\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.22) was associated with increased ALS risk, whereas higher plasma concentration of phenylalanylserine, isobutyrylcarnitine, and acetylcarnitine was protective (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20095e\u2009\u2212\u20095,\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009= \u2212\u20090.29 to\u2009\u2212\u20090.72). DSGEGDFXAEGGGVR has been linked to glucose metabolism but we have used genetic fine-mapping to link DSGEGDFXAEGGGVR, neuronal glucose uptake through GLUT3, and ALS risk. Direct measurement of metabolite concentrations in patient biofluids revealed elevated acetylcarnitine levels in patients with ALS, which were associated with delayed symptom onset (Cox regression,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02,\n                      <jats:italic>HR<\/jats:italic>\n                      \u2009=\u20090.4). Similarly, lactate is elevated in ALS patient CSF (ANOVA,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20091.3e\u2009\u2212\u20093) and in patients with longer survival time (Cox regression,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03,\n                      <jats:italic>HR<\/jats:italic>\n                      \u2009=\u20090.3). Plasma fructose is elevated in ALS patients with shorter survival time (Cox regression,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02,\n                      <jats:italic>HR<\/jats:italic>\n                      \u2009=\u20091.1). In vitro, neurons and astrocytes carrying an ALS-associated G4C2-repeat expansion within\n                      <jats:italic>C9orf72<\/jats:italic>\n                      demonstrated reduced metabolic flexibility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We provide evidence that impaired energy substrate availability contributes to ALS risk and severity. CNS cell types differ in their use of energy substrates and therefore we postulate the relative importance of different cell types for different stages of disease. Our findings support further investigation of metabolic interventions to treat or prevent ALS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04727-w","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:53:34Z","timestamp":1772758414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Elham","family":"Alhathli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Cooper-Knock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain-Ul-Abideen","family":"Girach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah O.","family":"Timmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billie D.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimoun","family":"Azzouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elrayess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Al-Khelaifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha A.","family":"Yousri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytac","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Kelsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gornall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"12","key":"4727_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(12):942\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(10)61156-7.","journal-title":"Lancet"},{"key":"4727_CR2","doi-asserted-by":"crossref","unstructured":"Nalbantoglu S. Metabolomics: basic principles and strategies. In: Molecular medicine. IntechOpen; 2019. Available from: https:\/\/www.intechopen.com\/books\/molecular-medicine\/metabolomics-basic-principles-and-strategies.","DOI":"10.5772\/intechopen.88563"},{"key":"4727_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.792227","volume":"12","author":"A Schumacher-Schuh","year":"2021","unstructured":"Schumacher-Schuh A, Bieger A, Borelli WV, Portley MK, Awad PS, Bandres-Ciga S. Advances in proteomic and metabolomic profiling of neurodegenerative diseases. Front Neurol. 2021;12:792227. https:\/\/doi.org\/10.3389\/fneur.2021.792227.","journal-title":"Front Neurol"},{"key":"4727_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12090837","author":"C Marino","year":"2022","unstructured":"Marino C, Grimaldi M, Sommella EM, Ciaglia T, Santoro A, Buonocore M, et al. The metabolomic profile in amyotrophic lateral sclerosis changes according to the progression of the disease: an exploratory study. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12090837.","journal-title":"Metabolites"},{"issue":"29","key":"4727_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/brain\/awab420","volume":"145","author":"TH Julian","year":"2022","unstructured":"Julian TH, Boddy S, Islam M, Kurz J, Whittaker KJ, Moll T, et al. A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 2022;145(29):832\u201342. https:\/\/doi.org\/10.1093\/brain\/awab420.","journal-title":"Brain"},{"key":"4727_CR6","doi-asserted-by":"publisher","unstructured":"Boddy S, Islam M, Moll T, Kurz J, Burrows D, McGown A, et al. Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis. Brain Commun. 2022;4(2):fcac069. Available from: https:\/\/doi.org\/10.1093\/braincomms\/fcac069.","DOI":"10.1093\/braincomms\/fcac069"},{"issue":"12","key":"4727_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen W, van der Spek RAA, Bakker MK, van Vugt JJFA, Hop PJ, Zwamborn RAJ, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636\u201348. https:\/\/doi.org\/10.1038\/s41588-021-00973-1.","journal-title":"Nat Genet"},{"issue":"4","key":"4727_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","volume":"90","author":"Y Liu","year":"2016","unstructured":"Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS\/FTD. Neuron. 2016;90(4):521\u201334. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.005.","journal-title":"Neuron"},{"issue":"6","key":"4727_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543\u201350. https:\/\/doi.org\/10.1038\/ng.2982.","journal-title":"Nat Genet"},{"key":"4727_CR10","doi-asserted-by":"publisher","unstructured":"Kettunen J, Demirkan A, W\u00fcrtz P, Draisma HHM, Haller T, Rawal R, et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 2016;7:11122. Available from: https:\/\/doi.org\/10.1038\/ncomms11122.","DOI":"10.1038\/ncomms11122"},{"key":"4727_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnmrs.2017.01.001","volume":"100","author":"DD Marshall","year":"2017","unstructured":"Marshall DD, Powers R. Beyond the paradigm: combining mass spectrometry and nuclear magnetic resonance for metabolomics. Prog Nucl Magn Reson Spectrosc. 2017;100:1\u201316. https:\/\/doi.org\/10.1016\/j.pnmrs.2017.01.001.","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"issue":"6","key":"4727_CR12","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ije\/dyx028","volume":"45","author":"FP Hartwig","year":"2016","unstructured":"Hartwig FP, Davies NM, Hemani G, Davey Smith G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;45(6):1717\u201326. https:\/\/doi.org\/10.1093\/ije\/dyx028.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4727_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"4727_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8208","volume":"6","author":"HHM Draisma","year":"2015","unstructured":"Draisma HHM, Pool R, Kobl M, Jansen R, Petersen AK, Vaarhorst AAM, et al. Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels. Nat Commun. 2015;6(1):7208. https:\/\/doi.org\/10.1038\/ncomms8208.","journal-title":"Nat Commun"},{"issue":"1","key":"4727_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67555-9","volume":"10","author":"F Al-Khelaifi","year":"2020","unstructured":"Al-Khelaifi F, Diboun I, Donati F, Botr\u00e8 F, Abraham D, Hingorani A, et al. Author correction: Metabolic GWAS of elite athletes reveals novel genetically-influenced metabolites associated with athletic performance. Sci Rep. 2020;10(1):10473. https:\/\/doi.org\/10.1038\/s41598-020-67555-9.","journal-title":"Sci Rep"},{"issue":"1","key":"4727_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55(1):44\u201353. https:\/\/doi.org\/10.1038\/s41588-022-01270-1.","journal-title":"Nat Genet"},{"issue":"11","key":"4727_CR17","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1038\/s41591-022-02046-0","volume":"28","author":"P Surendran","year":"2022","unstructured":"Surendran P, Stewart ID, Au Yeung VPW, Pietzner M, Raffler J, W\u00f6rheide MA, et al. Rare and common genetic determinants of metabolic individuality and their effects on human health. Nat Med. 2022;28(11):2321\u201332. https:\/\/doi.org\/10.1038\/s41591-022-02046-0.","journal-title":"Nat Med"},{"key":"4727_CR18","unstructured":"Byrne RP, van Rheenen W, Gomes TDS, Kelly CM, Ka\u00e7ar E, Project MinE ALS GWAS Consortium, et al. Sex-specific risk loci and modified MEF2C expression in ALS. medRxiv. 2024. p. 2024.05.25.24307829. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2024.05.25.24307829v1.abstract. Cited 2025 Jul 14."},{"issue":"7","key":"4727_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"key":"4727_CR20","doi-asserted-by":"publisher","unstructured":"Bowden J, Spiller W, Del Greco M F, Sheehan N, Thompson J, Minelli C, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol. 2018;47(4):1264\u201378. Available from: https:\/\/doi.org\/10.1093\/ije\/dyy101.","DOI":"10.1093\/ije\/dyy101"},{"issue":"6","key":"4727_CR21","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961\u201374. https:\/\/doi.org\/10.1093\/ije\/dyw220.","journal-title":"Int J Epidemiol"},{"key":"4727_CR22","doi-asserted-by":"publisher","unstructured":"Therneau TM. survival: survival analysis. CRAN: contributed packages. The R Foundation; 2001. Available from: https:\/\/doi.org\/10.32614\/cran.package.survival.","DOI":"10.32614\/cran.package.survival"},{"issue":"2","key":"4727_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.1314085111","volume":"111","author":"K Meyer","year":"2014","unstructured":"Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S A. 2014;111(2):829\u201332. https:\/\/doi.org\/10.1073\/pnas.1314085111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4727_CR24","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/brain\/awz302","volume":"142","author":"SP Allen","year":"2019","unstructured":"Allen SP, Hall B, Woof R, Francis L, Gatto N, Shaw AC, et al. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain. 2019;142(12):3771\u201390. https:\/\/doi.org\/10.1093\/brain\/awz302.","journal-title":"Brain"},{"issue":"1","key":"4727_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1321-6","volume":"15","author":"MA Connelly","year":"2017","unstructured":"Connelly MA, Otvos JD, Shalaurova I, Playford MP, Mehta NN. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J Transl Med. 2017;15(1):219. https:\/\/doi.org\/10.1186\/s12967-017-1321-6.","journal-title":"J Transl Med"},{"issue":"2","key":"4727_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/db21-0490","volume":"71","author":"NA Yousri","year":"2022","unstructured":"Yousri NA, Suhre K, Yassin E, Al-Shakaki A, Robay A, Elshafei M, et al. Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia. Diabetes. 2022;71(2):184\u2013205. https:\/\/doi.org\/10.2337\/db21-0490.","journal-title":"Diabetes"},{"key":"4727_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.933526","volume":"9","author":"P Weinisch","year":"2022","unstructured":"Weinisch P, Fiamoncini J, Schranner D, Raffler J, Skurk T, Rist MJ, et al. Dynamic patterns of postprandial metabolic responses to three dietary challenges. Front Nutr. 2022;9:933526. https:\/\/doi.org\/10.3389\/fnut.2022.933526.","journal-title":"Front Nutr"},{"issue":"10","key":"4727_CR28","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta Mol Cell Res. 2016;1863(10):2422\u201335. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.023.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"7","key":"4727_CR29","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1083\/jcb.201803152","volume":"217","author":"G Yellen","year":"2018","unstructured":"Yellen G. Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism. J Cell Biol. 2018;217(7):2235\u201346. https:\/\/doi.org\/10.1083\/jcb.201803152.","journal-title":"J Cell Biol"},{"key":"4727_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105874","volume":"174","author":"R Afridi","year":"2022","unstructured":"Afridi R, Rahman MH, Suk K. Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases. Neurobiol Dis. 2022;174:105874. https:\/\/doi.org\/10.1016\/j.nbd.2022.105874.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"4727_CR31","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","volume":"33","author":"G Bonvento","year":"2021","unstructured":"Bonvento G, Bola\u00f1os JP. Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metab. 2021;33(8):1546\u201364. https:\/\/doi.org\/10.1016\/j.cmet.2021.07.006.","journal-title":"Cell Metab"},{"key":"4727_CR32","doi-asserted-by":"publisher","unstructured":"Yee SW, Giacomini MM, Hsueh CH, Weitz D, Liang X, Goswami S, et al. Metabolomic and genome-wide association studies reveal potential endogenous biomarkers for OATP1B1. Clin Pharmacol Ther. 2016;100(5):524\u201336. Available from: https:\/\/doi.org\/10.1002\/cpt.434.","DOI":"10.1002\/cpt.434"},{"issue":"9","key":"4727_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in brain in health and disease. Pflugers Arch Eur J Physiol. 2020;472(9):1299\u2013343. https:\/\/doi.org\/10.1007\/s00424-020-02441-x.","journal-title":"Pflugers Arch Eur J Physiol"},{"issue":"1","key":"4727_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010001","volume":"13","author":"MS Spagnuolo","year":"2020","unstructured":"Spagnuolo MS, Iossa S, Cigliano L. Sweet but bitter: focus on fructose impact on brain function in rodent models. Nutrients. 2020;13(1):1. https:\/\/doi.org\/10.3390\/nu13010001.","journal-title":"Nutrients"},{"issue":"1","key":"4727_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbadis.2017.10.012","volume":"1864","author":"A Jim\u00e9nez-Maldonado","year":"2018","unstructured":"Jim\u00e9nez-Maldonado A, Ying Z, Byun HR, Gomez-Pinilla F. Short-term fructose ingestion affects the brain independently from establishment of metabolic syndrome. Biochim Biophys Acta Mol Basis Dis. 2018;1864(1):24\u201333. https:\/\/doi.org\/10.1016\/j.bbadis.2017.10.012.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"4727_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/brain\/awr365","volume":"135","author":"J Cooper-Knock","year":"2012","unstructured":"Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135(3):751\u201364. https:\/\/doi.org\/10.1093\/brain\/awr365.","journal-title":"Brain"},{"key":"4727_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052.","journal-title":"Neurosci Lett"},{"issue":"2","key":"4727_CR38","doi-asserted-by":"publisher","first-page":"a009332","DOI":"10.1101\/cshperspect.a009332","volume":"2","author":"C Perier","year":"2012","unstructured":"Perier C, Vila M. Mitochondrial biology and Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(2):a009332. https:\/\/doi.org\/10.1101\/cshperspect.a009332.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4727_CR39","doi-asserted-by":"publisher","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Vol. 15, Molecular Neurodegeneration. 2020. Available from: https:\/\/doi.org\/10.1186\/s13024-020-00376-6.","DOI":"10.1186\/s13024-020-00376-6"},{"key":"4727_CR40","doi-asserted-by":"publisher","unstructured":"Chen C, Turnbull DM, Reeve AK. Mitochondrial dysfunction in Parkinson\u2019s disease\u2014cause or consequence? Biology. 2019; 8:38. Available from: https:\/\/doi.org\/10.3390\/biology8020038.","DOI":"10.3390\/biology8020038"},{"issue":"4","key":"4727_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","volume":"135","author":"T Vandoorne","year":"2018","unstructured":"Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135(4):489\u2013509. https:\/\/doi.org\/10.1007\/s00401-018-1835-x.","journal-title":"Acta Neuropathol"},{"key":"4727_CR42","doi-asserted-by":"crossref","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17023659.","DOI":"10.1126\/science.1134108"},{"issue":"8","key":"4727_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22(8):869\u201378. https:\/\/doi.org\/10.1038\/nm.4130.","journal-title":"Nat Med"},{"issue":"3","key":"4727_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24975","volume":"10","author":"C Harvey","year":"2024","unstructured":"Harvey C, Weinreich M, Lee JAK, Shaw AC, Ferraiuolo L, Mortiboys H, et al. Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis. Heliyon. 2024;10(3):e24975. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24975.","journal-title":"Heliyon"},{"key":"4727_CR45","doi-asserted-by":"publisher","unstructured":"ALSUntangled 53: carnitine supplements. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5\u20136):477\u201383. Available from: https:\/\/doi.org\/10.1080\/21678421.2020.1726565.","DOI":"10.1080\/21678421.2020.1726565"},{"key":"4727_CR46","doi-asserted-by":"publisher","unstructured":"Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177(6):1522\u201335.e14. Available from: https:\/\/doi.org\/10.1016\/j.cell.2019.04.001.","DOI":"10.1016\/j.cell.2019.04.001"},{"issue":"12","key":"4727_CR47","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1007\/s10072-025-08432-z","volume":"46","author":"Z Xie","year":"2025","unstructured":"Xie Z, Gai F, Liu L, Guo Y, Jiang H, Zhang W, et al. Acetylcarnitine in cerebrospinal fluid and blood as a protective factor for neuromyelitis optica spectrum disorders: a Mendelian randomization study. Neurol Sci. 2025;46(12):6697\u2013707. https:\/\/doi.org\/10.1007\/s10072-025-08432-z.","journal-title":"Neurol Sci"},{"key":"4727_CR48","doi-asserted-by":"publisher","unstructured":"Pineda SS, Lee H, Ulloa-Navas MJ, Linville RM, Garcia FJ, Galani K, et al. Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD. Cell. 2024;187(8):1971\u201389.e16. Available from: https:\/\/doi.org\/10.1016\/j.cell.2024.02.031.","DOI":"10.1016\/j.cell.2024.02.031"},{"key":"4727_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuint.2017.09.003","volume":"117","author":"SM Jaber","year":"2018","unstructured":"Jaber SM, Bordt EA, Bhatt NM, Lewis DM, Gerecht S, Fiskum G, et al. Sex differences in the mitochondrial bioenergetics of astrocytes but not microglia at a physiologically relevant brain oxygen tension. Neurochem Int. 2018;117:82\u201390. https:\/\/doi.org\/10.1016\/j.neuint.2017.09.003.","journal-title":"Neurochem Int"},{"issue":"2","key":"4727_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ymgme.2010.03.006","volume":"100","author":"PM Eskelin","year":"2010","unstructured":"Eskelin PM, Laitinen KA, Tyni TA. Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication? Mol Genet Metab. 2010;100(2):204\u20136. https:\/\/doi.org\/10.1016\/j.ymgme.2010.03.006.","journal-title":"Mol Genet Metab"},{"key":"4727_CR51","doi-asserted-by":"publisher","unstructured":"Peluso G, Petillo O, Margarucci S, Mingrone G, Greco AV, Indiveri C, et al. Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients. Front Biosci. 2002;7(1):a109\u201316. Available from: https:\/\/doi.org\/10.2741\/A745.","DOI":"10.2741\/A745"},{"issue":"10","key":"4727_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrendo.2015.129","volume":"11","author":"CS McCoin","year":"2015","unstructured":"McCoin CS, Knotts TA, Adams SH. Acylcarnitines--old actors auditioning for new roles in metabolic physiology. Nat Rev Endocrinol. 2015;11(10):617\u201325. https:\/\/doi.org\/10.1038\/nrendo.2015.129.","journal-title":"Nat Rev Endocrinol"},{"issue":"7408","key":"4727_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487(7408):443\u20138. https:\/\/doi.org\/10.1038\/nature11314.","journal-title":"Nature"},{"key":"4727_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.680104","volume":"15","author":"H Chen","year":"2021","unstructured":"Chen H, Qiao J, Wang T, Shao Z, Huang S, Zeng P. Assessing causal relationship between human blood metabolites and five neurodegenerative diseases with GWAS summary statistics. Front Neurosci. 2021;15:680104. https:\/\/doi.org\/10.3389\/fnins.2021.680104.","journal-title":"Front Neurosci"},{"key":"4727_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.physbeh.2013.07.014","volume":"122","author":"S Gao","year":"2013","unstructured":"Gao S, Moran TH, Lopaschuk GD, Butler AA. Hypothalamic malonyl-CoA and the control of food intake. Physiol Behav. 2013;122:17\u201324. https:\/\/doi.org\/10.1016\/j.physbeh.2013.07.014.","journal-title":"Physiol Behav"},{"issue":"49","key":"4727_CR56","doi-asserted-by":"publisher","first-page":"19285","DOI":"10.1073\/pnas.0709778104","volume":"104","author":"MJ Wolfgang","year":"2007","unstructured":"Wolfgang MJ, Cha SH, Sidhaye A, Chohnan S, Cline G, Shulman GI, et al. Regulation of hypothalamic malonyl-CoA by central glucose and leptin. Proc Natl Acad Sci U S A. 2007;104(49):19285\u201390. https:\/\/doi.org\/10.1073\/pnas.0709778104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4727_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1753-0407.2009.00043.x","volume":"1","author":"E Joly","year":"2009","unstructured":"Joly E, Roduit R, Peyot ML, Habinowski SA, Ruderman NB, Witters LA, et al. Glucose represses PPAR\u03b1 gene expression via AMP-activated protein kinase but not via p38 mitogen-activated protein kinase in the pancreatic \u03b2-cell. J Diabetes. 2009;1(4):263\u201372. https:\/\/doi.org\/10.1111\/j.1753-0407.2009.00043.x.","journal-title":"J Diabetes"},{"issue":"5","key":"4727_CR58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.15252\/emmm.201404433","volume":"7","author":"L Palamiuc","year":"2015","unstructured":"Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med. 2015;7(5):526\u201346. https:\/\/doi.org\/10.15252\/emmm.201404433.","journal-title":"EMBO Mol Med"},{"issue":"10492","key":"4727_CR59","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(25)00262-4","volume":"405","author":"G Bensimon","year":"2025","unstructured":"Bensimon G, Leigh PN, Tree T, Malaspina A, Payan CA, Pham HP, et al. Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial. Lancet. 2025;405(10492):1837\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(25)00262-4.","journal-title":"Lancet"},{"issue":"1","key":"4727_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","volume":"7","author":"TR Koves","year":"2008","unstructured":"Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7(1):45\u201356. https:\/\/doi.org\/10.1016\/j.cmet.2007.10.013.","journal-title":"Cell Metab"},{"issue":"9","key":"4727_CR61","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.4103\/1673-5374.276333","volume":"15","author":"SP Allen","year":"2020","unstructured":"Allen SP. Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis? Neural Regen Res. 2020;15(9):1654\u20135. https:\/\/doi.org\/10.4103\/1673-5374.276333.","journal-title":"Neural Regen Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04727-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04727-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04727-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:58:41Z","timestamp":1776081521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04727-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04727-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7811456\/v1","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Metabolic profiling of biofluids: Metabolic profiling of biofluids donated by ALS patients and controls as part of the AMBRoSIA project was approved by an NHS Research Ethics Committee (\n                      16\/LO\/2136\n                      ). Also, this study followed study protocols approved by Medical Ethical Committees for each of the participating institutions. Written informed consent was obtained from all participating individuals. In vitro study of human astrocytes: Ethical approval informed consent was obtained from all human subjects before skin sample collection (Study number STH16573 and STH16350, Research Ethics Committee reference 12\/YH\/0330). Fibroblasts obtained via Cedars-Sinai are covered by an MTA. All methods were performed in accordance with relevant national and international guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}